Esophageal Diseases  >>  Estybon (rigosertib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Estybon (rigosertib) / Traws Pharma, SymBio Pharma, Knight Therap
NCT01807546: Oral Rigosertib for Squamous Cell Carcinoma

Checkmark For head and neck squamous cell carcinoma
Dec 2013 - Dec 2013: For head and neck squamous cell carcinoma
Checkmark
Apr 2013 - Apr 2013: 
Completed
2
64
US
rigosertib, ON 01910.Na
Onconova Therapeutics, Inc.
Head and Neck Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Skin Squamous Cell Carcinoma, Penile Squamous Cell Carcinoma
03/15
04/16

Download Options